2/15/24 16:21 | 2/14/24 | LRMR | Larimar Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | PA | D | | P | 22 | 11.00 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
3/14/23 08:30 | 3/10/23 | ORTX | Orchard Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | M.d | 9 | 0.4591 | 0 | 20 | 28 | 92 | D | | | | | | | | | | | | | | |
2/13/23 08:09 | 2/9/23 | ORTX | Orchard Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | M.d | 9 | 0.4591 | 0 | 20 | 38 | 72 | D | | | | | | | | | | | | | | |
4/4/22 16:15 | 4/1/22 | ORTX | Orchard Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | P | 7 | 0.7474 | 0 | 10 | 24 | 52 | D | | | | | | | | | | | | | | |
2/1/21 16:15 | 1/29/21 | ORTX | Orchard Therapeutics Plc | | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | M.d | 24 | 2.44 | 0 | 10 | 31 | 42 | D | | | | | | | | | | | | | | |
6/15/20 17:03 | 6/11/20 | ORTX | Orchard Therapeutics Plc | | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | M.d | 24 | 2.44 | 0 | 10 | 66 | 25 | D | | | | | | | | | | | | | | |
8/7/15 17:24 | 8/5/15 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | P,COO | M.d | 224 | 14.91 | 33 | 15 | 16 | 109 | D | 184 | 227 | 59 | 14 | -8 | -13 | 0 | 0 | 1 | -3 | -6 | -52 | -63 | -56 |
8/7/15 17:24 | 8/5/15 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | P,COO | S.d | -1,003 | 66.85 | 33 | -15 | -12 | 109 | D | 184 | 227 | 59 | 14 | -8 | -13 | 0 | 0 | 1 | -3 | -6 | -52 | -63 | -56 |
6/8/15 16:35 | 6/4/15 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | P,COO | S | -1,389 | 69.47 | 33 | -20 | -15 | 109 | D | 276 | 294 | 81 | 39 | 19 | 15 | 7 | 6 | 0 | -3 | 1 | -12 | -60 | -68 |
1/4/13 16:34 | 1/3/13 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | EVP,COO | M.d | 0 | 0.00 | 1 | 20 | 999% | 22 | D | -13 | -17 | 1 | -13 | 6 | 6 | 4 | 7 | 0 | 2 | -1 | 45 | 41 | 49 |
1/4/13 16:34 | 1/3/13 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | EVP,COO | S.d | -156 | 15.60 | 1 | -10 | -31 | 22 | D | -13 | -17 | 1 | -13 | 6 | 6 | 4 | 7 | 0 | 2 | -1 | 45 | 41 | 49 |
12/4/12 07:26 | 11/30/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | EVP,COO | M.d | 0 | 0.00 | 1 | 10 | 500 | 12 | D | -3 | -15 | 12 | 3 | -12 | 4 | 2 | 1 | 0 | -5 | 3 | 20 | 25 | 65 |
12/4/12 07:26 | 11/30/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | EVP,COO | S.d | -75 | 15.08 | 1 | -5 | -29 | 12 | D | -3 | -15 | 12 | 3 | -12 | 4 | 2 | 1 | 0 | -5 | 3 | 20 | 25 | 65 |
4/2/12 16:00 | 4/2/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 15.86 | 2 | 1 | 33 | 2 | D | -55 | -5 | 8 | -16 | -7 | -1 | 0 | -1 | 1 | -1 | -2 | -2 | 13 | 49 |
3/2/12 16:21 | 3/1/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 15.81 | 2 | 1 | 50 | 2 | D | -55 | -11 | 8 | -8 | -9 | -4 | -7 | -5 | 1 | 4 | 0 | -13 | -7 | 12 |
2/2/12 09:35 | 2/1/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 16.56 | 2 | 1 | 100 | 1 | D | -63 | -7 | 15 | 17 | -10 | -10 | 5 | -1 | 1 | 2 | -3 | -3 | -9 | -2 |
1/4/12 16:00 | 1/3/12 | AMAG | Amag Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,COO, | P.d | 10 | 19.10 | 3 | 1 | New | 1 | D | -51 | 4 | -1 | 35 | 13 | 1 | -2 | -1 | -2 | -6 | -11 | -15 | -17 | -13 |
8/22/07 18:23 | 8/22/07 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | DO | P,CEO | P | 11 | 2.12 | 0 | 5 | 7 | 72 | D | -59 | -35 | 46 | -7 | 2 | -1 | -1 | 2 | 1 | -4 | -12 | -17 | -44 | -80 |
11/2/05 16:24 | 11/2/05 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,SVP | M.d | 6 | 5.63 | 0 | 1 | 8 | 14 | D | | 12 | 13 | 3 | 7 | -24 | -28 | -16 | 1 | -2 | -21 | -20 | -38 | -80 |
9/15/05 13:54 | 9/14/05 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,SVP | M.d | 6 | 5.63 | 0 | 1 | 8 | 13 | D | | 0 | -10 | 1 | -5 | -2 | 2 | 2 | 1 | 1 | 46 | 13 | -12 | -53 |
4/26/05 17:52 | 4/28/04 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,SVP | M.ad | 56 | 5.63 | 0 | 10 | New | 10 | D | | | -1 | -21 | -12 | 12 | 14 | 13 | 0 | 0 | 2 | 15 | 54 | -11 |
4/26/05 17:50 | 1/25/05 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,SVP | M.a | 11 | 5.63 | 0 | 2 | 20 | 12 | D | | | -1 | -21 | -12 | 12 | 14 | 13 | 0 | 0 | 2 | 15 | 54 | -11 |
1/25/05 15:49 | 1/25/05 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,SVP | M.d | 11 | 5.63 | 0 | 2 | 2 | 120 | D | | | 15 | 25 | 2 | -3 | -1 | -3 | 0 | -12 | -11 | -21 | -14 | -19 |
2/9/04 21:31 | 2/5/04 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MI | O | VP,Finan | M.d | 0 | 0.00 | 0 | 47 | | 0 | D | | | | | | | | | | | | | | |
1/2/04 18:49 | 12/30/03 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MI | O | VP,Finan | M | 5 | 5.00 | 0 | 1 | 105 | 2 | D | | | | | | | | | | | | | | |
9/15/03 08:42 | 9/11/03 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MI | O | VP,Finan | M | 50 | 5.00 | 0 | 10 | | 1 | D | | | | | | | | | | | | | | |
9/15/03 08:42 | 9/11/03 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MI | O | VP,Finan | S | -184 | 18.40 | 0 | -10 | -93 | 1 | D | | | | | | | | | | | | | | |
8/28/03 20:00 | 8/26/03 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MI | O | VP,Finan | S | -24 | 16.00 | 0 | -2 | -66 | 1 | D | | | | | | | | | | | | | | |